Cargando…

α-Tocopheryl Succinate Inhibits Osteolytic Bone Metastasis of Breast Cancer by Suppressing Migration of Cancer Cells and Receptor Activator of Nuclear Factor-κB Ligand Expression of Osteoblasts

BACKGROUND: Breast cancer is one of the most common cancers affecting women and has a high incidence of bone metastasis, causing osteolytic lesions. The elevated expression of receptor activator of nuclear factor-κB ligand (RANKL) in cancer activates osteoclasts, leading to bone destruction. We prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Bongjun, Kim, Hong-Hee, Lee, Zang Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Bone and Mineral Research 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854820/ https://www.ncbi.nlm.nih.gov/pubmed/29564303 http://dx.doi.org/10.11005/jbm.2018.25.1.23

Ejemplares similares

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
por: Kim, Ha-Neui, et al.
Publicado: (2012)

Selective cancer cell killing by α-tocopheryl succinate
por: Neuzil, J, et al.
Publicado: (2001)

An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy
por: Lee, Song Yi, et al.
Publicado: (2018)

Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases
por: Srivastava, Ajay, et al.
Publicado: (2019)

Intraperitoneal administration of nanoparticles containing tocopheryl succinate prevents peritoneal dissemination
por: Hama, Susumu, et al.
Publicado: (2022)

α-Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activation
por: Dalen, H, et al.
Publicado: (2003)

The Combination of α-Tocopheryl Succinate and Sodium Selenite on Breast Cancer: A Merit or a Demerit?
por: Badr, Doaa M., et al.
Publicado: (2016)

Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy
por: Tan, Songwei, et al.
Publicado: (2017)

Tocopheryl Succinate-Induced Structural Changes in DPPC Liposomes: DSC and ANS Fluorescence Studies
por: Neunert, Grażyna, et al.
Publicado: (2020)

Synthesis, Colloidal Characterization and Targetability of Phenylboronic Acid Functionalized α-Tocopheryl Polyethylene Glycol Succinate in Cancer Cells
por: Tiwari, Sanjay, et al.
Publicado: (2020)

α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells
por: Tomasetti, M, et al.
Publicado: (2004)

Effect of α-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cells
por: PEKMEZ, MURAT, et al.
Publicado: (2015)

α-Tocopheryl Succinate-Based Polymeric Nanoparticles for the Treatment of Head and Neck Squamous Cell Carcinoma
por: Sánchez-Rodríguez, Carolina, et al.
Publicado: (2018)

Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
por: Shiirevnyamba, A, et al.
Publicado: (2011)

Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment
por: Ma, Yuandong, et al.
Publicado: (2010)

Correction to: Tan et al., Recent developments in D-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy
Publicado: (2017)

α-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate
por: Tomasetti, M, et al.
Publicado: (2010)

Mitochondrial Pathway of α-Tocopheryl Succinate-Induced Apoptosis in Human Epidermoid Carcinoma A431 Cells
por: Savitskaya, M.A., et al.
Publicado: (2012)

Alpha-Tocopheryl Succinate Inhibits Autophagic Survival of Prostate Cancer Cells Induced by Vitamin K3 and Ascorbate to Trigger Cell Death
por: Tomasetti, Marco, et al.
Publicado: (2012)

Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pancreatic Cancer
por: Debele, Tilahun Ayane, et al.
Publicado: (2020)

BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation()()
por: Pan, Tianhong, et al.
Publicado: (2017)

d-a-Tocopheryl Polyethylene Glycol 1000 Succinate and a small-molecule Survivin suppressant synergistically induce apoptosis in SKBR3 breast cancer cells
por: Neophytou, Christiana M., et al.
Publicado: (2019)

Succinate dehydrogenase expression in breast cancer
por: Kim, Sewha, et al.
Publicado: (2013)

Data on the expression of CXCR3 ligands and pro-inflammatory cytokines in macrophages and CD4(+) T cells after stimuli of CXCR3 ligands
por: Kim, Bongjun, et al.
Publicado: (2018)

NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells
por: Jin, Won Jong, et al.
Publicado: (2017)

Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions
por: Sun, Deqing, et al.
Publicado: (2014)

Mitochondria-acting carrier-free nanoplatform self-assembled by α-tocopheryl succinate carrying cisplatin for combinational tumor therapy
por: Mei, Heng, et al.
Publicado: (2021)

Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-α-tocopheryl polyethylene glycol 1000 succinate
por: Ren, Tianming, et al.
Publicado: (2022)

Basigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions
por: Liao, Cheng-Gong, et al.
Publicado: (2016)

Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical
por: Shen, Roger, et al.
Publicado: (2016)

Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
por: Das, Shamik, et al.
Publicado: (2012)

Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy
por: Zhao, Tiejun, et al.
Publicado: (2013)

Characterization, in Vivo and in Vitro Evaluation of Solid Dispersion of Curcumin Containing d-α-Tocopheryl Polyethylene Glycol 1000 Succinate and Mannitol
por: Song, Im-Sook, et al.
Publicado: (2016)

A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer
por: Fradet, Anaïs, et al.
Publicado: (2013)

The Hedgehog Pathway Conditions the Bone Microenvironment for Osteolytic Metastasis of Breast Cancer
por: Das, Shamik, et al.
Publicado: (2012)

Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy
por: Chu, Qiuchen, et al.
Publicado: (2016)

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis
por: Lee, Sun Kyoung, et al.
Publicado: (2017)

Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo
por: Lei, Xiaoying, et al.
Publicado: (2017)

Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: in vivo murine model
por: Riestra-Ayora, Juan, et al.
Publicado: (2021)

P62: An emerging oncotarget for osteolytic metastasis
por: Zhang, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uucqrelsv53uiausned41qtt1q